These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3435667)

  • 21. Sulfamide derivatives as transition state analogue inhibitors for carboxypeptidase A.
    Park JD; Kim DH
    Bioorg Med Chem; 2004 May; 12(9):2349-56. PubMed ID: 15080932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic insight into the inactivation of carboxypeptidase A by alpha-benzyl-2-oxo-1,3-oxazolidine-4-acetic acid, a novel type of irreversible inhibitor for carboxypeptidase A with no stereospecificity.
    Chung SJ; Chung S; Lee HS; Kim EJ; Oh KS; Choi HS; Kim KS; Kim YJ; Hahn JH; Kim DH
    J Org Chem; 2001 Sep; 66(19):6462-71. PubMed ID: 11559199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of new immobilized-stabilized carboxypeptidase a derivative for production of aromatic free hydrolysates of proteins.
    Tardioli PW; Fernández-Lafuente R; Guisán JM; Giordano RL
    Biotechnol Prog; 2003; 19(2):565-74. PubMed ID: 12675602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enzyme intermediates with the C-terminal products of substrate hydrolysis by carboxypeptidase A and chymotrypsin. Use of the free energy linearity principle].
    Kozlov LV
    Biokhimiia; 1980 Aug; 45(8):1442-7. PubMed ID: 7236796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of carboxypeptidase-Y-catalyzed reaction deduced from a pressure-dependence study.
    Fukuda M; Kunugi S
    Eur J Biochem; 1985 Jun; 149(3):657-62. PubMed ID: 4006944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mechanism of action for carboxypeptidase A.
    Barber AK; Fisher JR
    Proc Natl Acad Sci U S A; 1972 Oct; 69(10):2970-4. PubMed ID: 4507617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of copper-substituted carboxypeptidase A toward oligopeptides and depsipeptides.
    Schäffer A; Auld DS
    Biochemistry; 1986 May; 25(9):2476-9. PubMed ID: 3013305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic analysis of the carboxypeptidase A hydrolysis of oligopeptides by reversed-phase high-performance liquid chromatography.
    Serra MA; Avilés FX; Giralt E; Cuchillo CM
    J Chromatogr; 1989 Sep; 479(1):27-37. PubMed ID: 2808595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new monoclonal anti-idiotypic catalytic antibody with a CPA-like activity.
    Du M; Guo Z; Jin S
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1487-92. PubMed ID: 10386922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and crystallization of human carboxypeptidase A.
    Peterson LM; Sokolovsky M; Vallee BL
    Biochemistry; 1976 Jun; 15(12):2501-8. PubMed ID: 938622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetrazole analogs of amino acids as constituents of modifiers of carboxypeptidase A catalysis.
    Kojro E; Willhardt I; Römbach A; Grzonka Z; Hermann P
    FEBS Lett; 1987 Feb; 212(1):83-6. PubMed ID: 3803610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The physical state dependence of carboxypeptidase Aalpha and Agamma kinetics.
    Spilburg CA; Bethune JL; Vallee BL
    Proc Natl Acad Sci U S A; 1974 Oct; 71(10):3922-6. PubMed ID: 4530272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An angiotensin converting enzyme inhibitor is a tight-binding slow substrate of carboxypeptidase A.
    Martin MT; Holmquist B; Riordan JF
    J Inorg Biochem; 1989 May; 36(1):39-50. PubMed ID: 2746220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substrate specificity of carboxypeptidase from Watermelon.
    Matoba T; Doi E
    J Biochem; 1975 Jun; 77(6):1297-303. PubMed ID: 5403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic studies of wheat carboxypeptidase-catalyzed reaction: differences in pressure and temperature dependence of peptidase and esterase activities.
    Fukuda M; Kunugi S
    J Biochem; 1987 Jan; 101(1):233-40. PubMed ID: 3553174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of analogues of an intermediate in the process of mechanism-based inactivation of carboxypeptidase A.
    Ghosh SS; Dakoji S; Tanaka Y; Cho YJ; Mobashery S
    Bioorg Med Chem; 1996 Sep; 4(9):1487-92. PubMed ID: 8894106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermostabilization of carboxypeptidase A by interaction with its monoclonal antibodies.
    Solomon B; Balas N
    Biotechnol Appl Biochem; 1991 Oct; 14(2):202-11. PubMed ID: 1760132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hippuryl-alpha-methylphenylalanine and hippuryl-alpha-methylphenyllactic acid as substrates for carboxypeptidase A. Syntheses, kinetic evaluation and mechanistic implication.
    Lee M; Kim DH
    Bioorg Med Chem; 2000 Apr; 8(4):815-23. PubMed ID: 10819170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of carboxypeptidase A with carbamate and carbonate esters.
    King SW; Lum VR; Fife TH
    Biochemistry; 1987 Apr; 26(8):2294-300. PubMed ID: 3620447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicochemical property modification strategies based on enzyme substrate specificities III: carboxypeptidase A hydrolysis of aspirin derivatives.
    Banerjee PK; Amidon GL
    J Pharm Sci; 1981 Dec; 70(12):1307-9. PubMed ID: 7320841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.